Evidence map›Paper›PMID 24965773›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells.

Josephine Thinwa, Jesus A Segovia, Santanu Bose, Peter H Dube

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Conditional deletion ofFrontiers in cell and developmental biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Integrin αProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. mBio · 2023
    Article
  9. Article
  10. bioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Frontiers in immunology · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Josephine ThinwaDepartment of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229; and.
Jesus A SegoviaDepartment of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229; and Center for Airway Inflammation Research, University of Texas Health Science Center, San Antonio, TX 78229.
Santanu BoseDepartment of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229; and Center for Airway Inflammation Research, University of Texas Health Science Center, San Antonio, TX 78229.
Peter H DubeDepartment of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229; and Center for Airway Inflammation Research, University of Texas Health Science Center, San Antonio, TX 78229 Dube@uthhscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infectionR01AI083387 · NIAID · WASHINGTON STATE UNIVERSITY · PI BOSE, SANTANU · 2010 to 2021
$3.1M
Role of IL-6 in the Pathogenesis of Yersinia enterocolitica infectionR01AI067716 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DUBE, PETER H · 2007 to 2011
$1.9M
MOLECULAR MECHANISMS OF MICROBIAL PATHOGENICITYT32AI007271 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 1985 to 2013
$1.0M
Host response to Yersinia pestis infectionR21AI060789 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DUBE, PETER H · 2007 to 2008
$399k
NIAID NIH HHS 5T32 AI007271NIAID NIH HHS AI060789NIAID NIH HHS AI067716NIAID NIH HHS AI083387NIAID NIH HHS R01 AI067716NIAID NIH HHS R01 AI083387NIAID NIH HHS R21 AI060789NIAID NIH HHS T32 AI007271
6 · The paper itself

Abstract

How intestinal epithelial cells (IECs) recognize pathogens and activate inflammasomes at intestinal surfaces is poorly understood. We hypothesized that IECs use integrin receptors to recognize pathogens and initiate inflammation within the intestinal tract. We find that IECs infected with Yersinia enterocolitica, an enteric pathogen, use β1 integrins as pathogen recognition receptors detecting the bacterial adhesin invasin (Inv). The Inv-integrin interaction provides the first signal for NLRP3 inflammasome activation with the type three secretion system translocon providing the second signal for inflammasome activation, resulting in release of IL-18. During infection, Yersinia employs two virulence factors, YopE and YopH, to counteract Inv-mediated integrin-dependent inflammasome activation. Furthermore, NLRP3 inflammasome activation in epithelial cells requires components of the focal adhesion complex signaling pathway, focal adhesion kinase, and rac1. The binding of Inv to β1 integrins rapidly induces IL-18 mRNA expression, suggesting integrins provide a first signal for NLRP3 inflammasome activation. These data suggest integrins function as pathogen recognition receptors on IECs to rapidly induce inflammasome-derived IL-18-mediated responses.

Indexed as

Adhesins, BacterialBacterial Outer Membrane ProteinsBacterial ToxinsCaco-2 CellsCarrier ProteinsCell Line, TumorEpithelial CellsHumansInflammasomesIntegrin alpha5beta1Interleukin-18Intestinal MucosaNLR Family, Pyrin Domain-Containing 3 ProteinProtein BindingProtein Tyrosine PhosphatasesSignal TransductionAdhesins, BacterialBacterial Outer Membrane ProteinsBacterial ToxinsCarrier ProteinsInflammasomesIntegrin alpha5beta1Interleukin-18invasin, YersiniaNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanProtein Tyrosine PhosphatasesVirulence FactorsyopE protein, YersiniayopH protein, Yersinia

Identifiers

PMID24965773
PMCPMC4174679
OpenAlexW2107849257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.